Overview

Determining the Safety of L-serine in ALS

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of L-Serine in subjects with Amyotrophic Lateral Sclerosis (ALS) at varied doses.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Phoenix Neurological Associates, LTD
Collaborator:
Institute for Ethnomedicine